Louise China

1.6k total citations · 2 hit papers
30 papers, 782 citations indexed

About

Louise China is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Louise China has authored 30 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 21 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Louise China's work include Liver Disease and Transplantation (22 papers), Liver Disease Diagnosis and Treatment (21 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Louise China is often cited by papers focused on Liver Disease and Transplantation (22 papers), Liver Disease Diagnosis and Treatment (21 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Louise China collaborates with scholars based in United Kingdom, France and Italy. Louise China's co-authors include Alastair O’Brien, Derek W. Gilroy, Ewan Forrest, Nick Freemantle, Stephen Ryder, Gavin Wright, Yiannis Kallis, Suvi Härmälä, Naaventhan Palaniyappan and Andrew J. Portal and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Louise China

28 papers receiving 771 citations

Hit Papers

Guidelines on the management of ascites in cirrhosis 2020 2026 2022 2024 2020 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines on the management of ascites in cirrhosis
    2020 240 citations Guruprasad P. Aithal, Naaventhan Palaniyappan et al. Gut profile →
  2. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis
    2021 194 citations Louise China, Nick Freemantle et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise China United Kingdom 13 515 448 249 109 93 30 782
Martin Eefsen Denmark 7 431 0.8× 257 0.6× 195 0.8× 62 0.6× 232 2.5× 9 602
Jan Freeman United Kingdom 18 374 0.7× 371 0.8× 455 1.8× 205 1.9× 51 0.5× 36 872
Tsung‐Hsing Hung Taiwan 15 350 0.7× 328 0.7× 226 0.9× 113 1.0× 35 0.4× 57 630
Thomas Sersté Belgium 16 883 1.7× 823 1.8× 424 1.7× 101 0.9× 88 0.9× 37 1.1k
Mireia Miquel Spain 15 594 1.2× 555 1.2× 283 1.1× 105 1.0× 56 0.6× 60 882
Robert L. Carithers United States 8 608 1.2× 406 0.9× 428 1.7× 94 0.9× 153 1.6× 8 878
Delphine Weil France 12 370 0.7× 355 0.8× 134 0.5× 51 0.5× 60 0.6× 36 566
Maria Kalafateli Greece 17 410 0.8× 414 0.9× 179 0.7× 32 0.3× 23 0.2× 49 943
Mathias Jachs Austria 18 738 1.4× 754 1.7× 251 1.0× 35 0.3× 74 0.8× 78 963
Iyad Kabar Germany 19 282 0.5× 217 0.5× 443 1.8× 218 2.0× 27 0.3× 54 1.0k

Countries citing papers authored by Louise China

Since Specialization
Citations

This map shows the geographic impact of Louise China's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise China with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise China more than expected).

Fields of papers citing papers by Louise China

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise China. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise China. The network helps show where Louise China may publish in the future.

Co-authorship network of co-authors of Louise China

This figure shows the co-authorship network connecting the top 25 collaborators of Louise China. A scholar is included among the top collaborators of Louise China based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise China. Louise China is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torp, Nikolaj, Louise China, Mads Israelsen, et al.. (2025). Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE. Annals of Hepatology. 30(2). 101941–101941. 1 indexed citations
2.
3.
Deltenre, Pierre, Audrey Payancé, Laure Elkrief, et al.. (2023). Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study. JHEP Reports. 5(11). 100894–100894. 8 indexed citations
4.
5.
6.
China, Louise, Ewan Forrest, Yiannis Kallis, et al.. (2022). Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: data from the ATTIRE trial. EClinicalMedicine. 55. 101716–101716. 6 indexed citations
7.
China, Louise, et al.. (2022). Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis. Clinical and Translational Gastroenterology. 13(5). e00476–e00476. 13 indexed citations
8.
Maan, Raoel, Aurélie Plessier, Louise China, et al.. (2022). New cases of Budd-Chiari syndrome and splanchnic vein thrombosis after COVID-19 vaccination-a vascular liver disease group (VALDIG) initiative. Journal of Hepatology. 77. S524–S525. 1 indexed citations
9.
Maini, Alexander A., Natalia Bécares, Louise China, et al.. (2021). Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway. JHEP Reports. 3(6). 100332–100332. 7 indexed citations
10.
Aithal, Guruprasad P., Naaventhan Palaniyappan, Louise China, et al.. (2020). Guidelines on the management of ascites in cirrhosis. Gut. 70(1). 9–29. 240 indexed citations breakdown →
11.
China, Louise, Simon S. Skene, Nicholas Freemantle, et al.. (2020). ATTIRE: Albumin to prevent infection in chronic liver failure: an interventional randomised controlled trial. Journal of Hepatology. 73. S115–S115. 3 indexed citations
12.
Maida, Marcello, Laith Alrubaiy, Tomislav Bokun, et al.. (2020). Current challenges and future needs of clinical and endoscopic training in gastroenterology: a European survey. SHILAP Revista de lepidopterología. 8(4). E525–E533. 16 indexed citations
13.
Patel, Vishal, Simon Goldenberg, Alberto Sánchez‐Fueyo, et al.. (2019). PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial. BMJ Open. 9(2). e023518–e023518. 21 indexed citations
14.
Bécares, Natalia, Suvi Härmälä, Louise China, et al.. (2019). Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality. Clinical Gastroenterology and Hepatology. 18(5). 1207–1215.e6. 11 indexed citations
15.
China, Louise, Simon S. Skene, Kate Bennett, et al.. (2018). ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial. BMJ Open. 8(10). e023754–e023754. 21 indexed citations
16.
China, Louise, Simon S. Skene, Zainib Shabir, et al.. (2017). Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial. Clinical Gastroenterology and Hepatology. 16(5). 748–755.e6. 19 indexed citations
17.
China, Louise, Alexander A. Maini, Simon S. Skene, et al.. (2017). Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease. Clinical Gastroenterology and Hepatology. 16(5). 738–747.e7. 49 indexed citations
18.
China, Louise, Nicola Muirhead, Simon S. Skene, et al.. (2016). ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial. BMJ Open. 6(1). e010132–e010132. 6 indexed citations
19.
China, Louise & Gavin Johnson. (2014). OC-050 The Ugib-dops: Improving Training In Gi Bleed Management In The Endoscopy Unit. Gut. 63(Suppl 1). A24.2–A25. 2 indexed citations
20.
zhuang, Zhuang, et al.. (1999). Partial sequencing of 5’ non-coding region of 7 HGV strains isolated from different areas of China. 世界胃肠病学杂志：英文版（电子版）. 432–434. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Eefsen Breakdown of academic impact, for papers by Jan Freeman Breakdown of academic impact, for papers by Tsung‐Hsing Hung Breakdown of academic impact, for papers by Thomas Sersté Breakdown of academic impact, for papers by Mireia Miquel Breakdown of academic impact, for papers by Robert L. Carithers Breakdown of academic impact, for papers by Delphine Weil Breakdown of academic impact, for papers by Maria Kalafateli Breakdown of academic impact, for papers by Mathias Jachs Breakdown of academic impact, for papers by Iyad Kabar
Rankless by CCL
2026